ATE299181T1 - Strukturelle analoge oberflächenschlaufen der fibroblasten-wachstumsfaktoren - Google Patents
Strukturelle analoge oberflächenschlaufen der fibroblasten-wachstumsfaktorenInfo
- Publication number
- ATE299181T1 ATE299181T1 AT94929876T AT94929876T ATE299181T1 AT E299181 T1 ATE299181 T1 AT E299181T1 AT 94929876 T AT94929876 T AT 94929876T AT 94929876 T AT94929876 T AT 94929876T AT E299181 T1 ATE299181 T1 AT E299181T1
- Authority
- AT
- Austria
- Prior art keywords
- fibroblast growth
- amino acid
- growth factors
- surface loop
- beta
- Prior art date
Links
- 102000018233 Fibroblast Growth Factor Human genes 0.000 title abstract 3
- 108050007372 Fibroblast Growth Factor Proteins 0.000 title abstract 3
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 3
- 108091008794 FGF receptors Proteins 0.000 abstract 1
- 102000003971 Fibroblast Growth Factor 1 Human genes 0.000 abstract 1
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 abstract 1
- 102000044168 Fibroblast Growth Factor Receptor Human genes 0.000 abstract 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 abstract 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 abstract 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 1
- 102000003777 Interleukin-1 beta Human genes 0.000 abstract 1
- 108090000193 Interleukin-1 beta Proteins 0.000 abstract 1
- 102000015696 Interleukins Human genes 0.000 abstract 1
- 108010063738 Interleukins Proteins 0.000 abstract 1
- 229940126864 fibroblast growth factor Drugs 0.000 abstract 1
- 229960002897 heparin Drugs 0.000 abstract 1
- 229920000669 heparin Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- C07K14/501—Fibroblast growth factor [FGF] acidic FGF [aFGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/545—IL-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Prostheses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12697393A | 1993-09-24 | 1993-09-24 | |
| US08/290,373 US5491220A (en) | 1993-09-24 | 1994-08-15 | Surface loop structural analogues of fibroblast growth factors |
| PCT/US1994/010800 WO1995008630A1 (en) | 1993-09-24 | 1994-09-23 | Surface loop structural analogues of fibroblast growth factors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE299181T1 true ATE299181T1 (de) | 2005-07-15 |
Family
ID=26825210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94929876T ATE299181T1 (de) | 1993-09-24 | 1994-09-23 | Strukturelle analoge oberflächenschlaufen der fibroblasten-wachstumsfaktoren |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0730651B1 (de) |
| JP (1) | JPH09503661A (de) |
| AT (1) | ATE299181T1 (de) |
| AU (1) | AU687455B2 (de) |
| CA (1) | CA2172137C (de) |
| DE (1) | DE69434420D1 (de) |
| NZ (1) | NZ274667A (de) |
| WO (1) | WO1995008630A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2201762C (en) * | 1994-10-13 | 2001-12-18 | Eric W. Hsu | Method for purifying keratinocyte growth factors |
| AU3893195A (en) * | 1994-10-13 | 1996-05-06 | Amgen, Inc. | Keratinocyte growth factor analogs |
| AU722626B2 (en) * | 1996-05-20 | 2000-08-10 | Abburi Ramaiah | Cosmetic preparation |
| US6743422B1 (en) | 1996-10-15 | 2004-06-01 | Amgen, Inc. | Keratinocyte growth factor-2 products |
| US6274712B1 (en) | 1997-12-23 | 2001-08-14 | 3-Dimensional Pharmaceuticals, Inc. | Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137 |
| AU3170499A (en) * | 1998-04-28 | 1999-11-16 | Eisai Co. Ltd. | Fibroblast growth factor mutein compositions and methods of use therefor |
| IL139380A0 (en) * | 2000-10-31 | 2001-11-25 | Prochon Biotech Ltd | Active variants of fibroblast growth factor |
| IL149562A0 (en) * | 2002-05-09 | 2002-11-10 | Prochon Ltd | Fgf variants and methods for use thereof |
| EP3380508B1 (de) * | 2015-11-27 | 2020-07-22 | Masarykova Univerzita | Thermostabiles fgf2-polypeptid, verwendung davon und kulturmedium thermostabilem fgf2-polypeptid |
| EP4067374A4 (de) | 2019-11-25 | 2024-03-06 | Korea Institute of Ocean Science and Technology | Fgf2-polypeptid mit verbesserter temperaturstabilität und proteaseresistenz und seine verwendung |
| KR102428940B1 (ko) * | 2019-11-25 | 2022-08-03 | 한국해양과학기술원 | 온도안정성 및 단백질 분해효소 저항성을 향상시킨 fgf2 폴리펩타이드 및 그 용도 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2526965B2 (ja) * | 1987-02-24 | 1996-08-21 | 武田薬品工業株式会社 | ムテイン,dnaおよびその用途 |
-
1994
- 1994-09-23 AT AT94929876T patent/ATE299181T1/de not_active IP Right Cessation
- 1994-09-23 EP EP94929876A patent/EP0730651B1/de not_active Expired - Lifetime
- 1994-09-23 NZ NZ274667A patent/NZ274667A/en unknown
- 1994-09-23 CA CA002172137A patent/CA2172137C/en not_active Expired - Fee Related
- 1994-09-23 DE DE69434420T patent/DE69434420D1/de not_active Expired - Lifetime
- 1994-09-23 WO PCT/US1994/010800 patent/WO1995008630A1/en not_active Ceased
- 1994-09-23 AU AU78784/94A patent/AU687455B2/en not_active Ceased
- 1994-09-23 JP JP7509963A patent/JPH09503661A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP0730651A4 (de) | 1997-12-03 |
| JPH09503661A (ja) | 1997-04-15 |
| EP0730651A1 (de) | 1996-09-11 |
| DE69434420D1 (de) | 2005-08-11 |
| WO1995008630A1 (en) | 1995-03-30 |
| AU687455B2 (en) | 1998-02-26 |
| CA2172137C (en) | 1999-12-14 |
| AU7878494A (en) | 1995-04-10 |
| EP0730651B1 (de) | 2005-07-06 |
| NZ274667A (en) | 1997-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE299181T1 (de) | Strukturelle analoge oberflächenschlaufen der fibroblasten-wachstumsfaktoren | |
| Darnall et al. | Subunit constitution of proteins: a table | |
| AU7180787A (en) | Fibroblast growth factor | |
| DE69021263D1 (de) | Fibronektinbindungsprotein und dessen Herstellung. | |
| EP1482044A3 (de) | Hämatopoietisches Fusionsprotein multivariantes IL-3 enthaltend | |
| ATE81779T1 (de) | Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren. | |
| NZ335109A (en) | Stable analogs of keratinocyte growth factor (KRF) useful for preventing alopecia, treating gastro-duodenal ulcers, bowel disease, liver function or general induction epithelial cell proliferation | |
| EP0442724A3 (en) | Modified hil-6 | |
| ATE372382T1 (de) | Ein faktor viii-polypeptid mit faktor viii:c- aktivität | |
| CA2075974A1 (en) | Totally synthetic affinity reagents | |
| CA2022752A1 (en) | Hepatic parenchymal cell growth factor, gene encoding the same, process for producing the factor, and transformants producing the factor | |
| PT84111A (de) | Peptide mit vasorelaxierender natriuretischer und diuretischer wirkung verfahren zu ihrer herstellung diese enthaltende mittelund ihre verwendung | |
| DE69131426D1 (de) | Neue wasserlösliche polypeptide mit hoher affinität für alpha- und beta- interferone | |
| ATE111520T1 (de) | Tgf beta 1/beta2: ein chimärer transformierender wachstumsfaktor. | |
| DE3853446D1 (de) | Fibronectinbindungsprotein und dessen Herstellung. | |
| DE69529674D1 (de) | Biologisch aktive ligande der eph familie | |
| NO971508L (no) | Analoger av sur fibroblastvekstfaktor med forökt stabilitet og biologisk aktivitet | |
| DE59409964D1 (de) | Rekombinante D-Hydantoinase, Verfahren zur Herstellung und Verwendung | |
| ATE109827T1 (de) | Verfahren zur herstellung von peptiden, dazu zu verwendendes rekombinantes plasmid und mit diesem plasmid transformierte myelomzellen. | |
| ATE46537T1 (de) | Promotor und dessen verwendung. | |
| TW264481B (en) | Surface loop structural analogues of fibroblast growth factors | |
| ES2044928T3 (es) | Enzima alfa-amidante en terminal c y procedimiento para la produccion y el uso del mismo. | |
| CA2067176A1 (en) | Recombinant gene coding for a protein having an endochitinase activity | |
| ATE254179T1 (de) | Neue type-i-interferon varianten, ihre verfahren zur herstellung, und ihre verwendungen | |
| ES8802185A1 (es) | Un metodo para preparar un anticuerpo util para la deteccion de un factor de crecimiento epidermico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |